Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us

Apta-Index™: DTA-64 (ID# 626)

Back to Search Results

DTA-64 (ID# 626)

DTA-64
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA DEK Protein N/A µM (reported value) Binding buffer (20 mM Tris pH 7.6; 100 mM NaCl; 5 mM MgCl2); Room Temperature (30 min - 1 hr, depending on round of testing). N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-dGpdGpdGpdGpdTpdTpdApdApdApdTpdApdTpdTpdCpdCpdCpdApdCpdApdTpdTpdGpdCpdCpdTpdGpdCpdGpdCpdCpdApdGpdTpdApdCpdApdApdApdTpdApdGp-3'
41 12593.25 g/mole 399100.00 L/(mole·cm) 46.34% 2.51 31.55

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

N Mor-Vaknin et al. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nature Communications 8(2017): 14252.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™